ClinConnect ClinConnect Logo
Search / Trial NCT04921098

CPC in Adult Refractory Glaucoma

Launched by SOHAG UNIVERSITY · Jun 4, 2021

Trial Information

Current as of July 04, 2025

Unknown status

Keywords

ClinConnect Summary

A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation.

Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Inclusion Criteria:
  • 1. Patients with refractory glaucoma aging 18 years and older.
  • 2. Both sexes are included.
  • 3. Patients Capable of giving informed consent.
  • 4. Pseudophkic glaucoma.
  • 5. Aphakic glaucoma.
  • 6. Silicon oil induced glaucoma.
  • 7. Neovascular glaucoma.
  • 8. Inflammatory glaucoma.
  • Exclusion Criteria:
  • 1. Patients \<18 years of age.
  • 2. Patients controlled on regular antiglaucomatous therapy.
  • 3. Patients who cannot do regular follow up visits.
  • 4. Diffuse scleral staphyloma at the site of CPC.

About Sohag University

Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.

Locations

Sohag, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials